The role of regorafenib in the treatment of metastatic colorectal cancer
Regorafenib is a multi-tyrosine kinase inhibitor, associated with the activity in metastatic colorectal cancer (mCRC) and gastrointestinal stromal tumors. Regorafenib application in patients with mCRC after exhausting all available drug therapies have resulted in statistically significant increase i...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IP Habib O.N.
2016-06-01
|
| Series: | Современная онкология |
| Subjects: | |
| Online Access: | https://modernonco.orscience.ru/1815-1434/article/viewFile/27080/pdf |